Navigation Links
OrthoAccel Technologies Announces Full-Market Release of AcceleDent, a New Technology to Shorten Treatment Time in Braces
Date:8/31/2010

HOUSTON, Aug. 31 /PRNewswire/ -- OrthoAccel Technologies, Inc. announced this week that following a successful limited market release of AcceleDent last October it will be initiating a full-market release throughout the United Kingdom this coming September.  Availability of AcceleDent, which is a regulated medical device and only available to dental professionals to prescribe to their patients, will be featured at the British Orthodontic Conference (BOC) next month in Brighton.

(Logo:  http://photos.prnewswire.com/prnh/20091029/DA01250LOGO)

(Logo:  http://www.newscom.com/cgi-bin/prnh/20091029/DA01250LOGO)

AcceleDent is a simple, removable dental device that patients place in the mouth for twenty minutes daily.  It produces a gentle vibrational force which enhances the pressure applied by braces.  AcceleDent has been clinically proven to safely speed up orthodontic tooth movement.  The product is hands-free and allows the user flexibility to carry out most routine tasks during use.  

The AcceleDent System is currently being sold to select orthodontic specialists in the United Kingdom, where it was introduced last year through a limited market release program.  Approximately twenty orthodontic specialists participated in the evaluation program, which the Company used as an important learning experience.  Mike Kaufman, VP Marketing and Business Development at OrthoAccel, commented, "The controlled UK introduction has provided an invaluable opportunity to experience customer purchasing preferences and marketing approaches to incorporate AcceleDent into the orthodontic treatment plan.  The ability to intimately dialogue with these early adopter orthodontists has yielded several product refinements, which have already been implemented.  These orthodontists are very encouraged by the results they are seeing and in general have been able to move through the treatment plan at a quicker pace."

Patients have reported using the device while engaged in a variety of activities, including homework, watching television and reading.  The vibrating force has been described as "very light," and one patient remarked, "The pulsing feels like a gentle massage for my teeth and gums – and I look forward to it every evening."  

And it seems that every patient has a unique story driving the desire to complete treatment and reach the final result of a beautiful smile as quickly as possible.  "I definitely want to finish treatment before I go to university, and plan to travel for the second six months of my gap year. Clear braces mean I don't feel nearly so self conscious and AcceleDent means I can expect to finish all my treatment by the end of this year - which is really great," remarked James, a 17 year old patient under the care of Dr Sharon Orton-Gibbs at Walpole Specialists, Surbiton.

The Company has reported plans to host a gathering at the BOC in Brighton next month for the group of early-user orthodontic specialists, in order to review patient case progress and other insights.  OrthoAccel is anticipating the conclusion of another US clinical trial at the UT Health Science Center in San Antonio with a target completion date later in 2010.

About OrthoAccel Technologies, Inc.

Based in Houston, Texas, OrthoAccel Technologies, Inc. is a privately owned medical device company currently engaged in the development, manufacturing, and marketing of products to enhance dental care and orthodontic treatment.  

About the AcceleDent System

AcceleDent represents the first clinical approach to safely accelerate orthodontic tooth movement via modulating biology.  The device has been studied clinically and applies gentle pulsing forces in combination with standard orthodontics to move teeth faster through accelerated bone remodeling. Importantly, the device works complementary with all existing orthodontic technologies.  AcceleDent is neither FDA cleared nor FDA approved; it is currently investigational only in the United States.  More information can be found at www.acceledent.com or requested via info@orthoaccel.com


'/>"/>
SOURCE OrthoAccel Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. OrthoAccel Technologies, Inc. and AB Orthodontics Announce Partnership and Australian Product Introduction
2. OrthoAccel Technologies, Inc. Announces Definitive Distribution Agreements in Two Key Markets
3. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
4. King Pharmaceuticals and Palatin Technologies Delay Immediate Plans for Phase 3 Clinical Program With Bremelanotide for Erectile Dysfunction
5. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
6. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
7. New Clinical Studies Confirm Mauna Kea Technologies Cellvizio(R) GI in Range of Procedures
8. Palatin Technologies, Inc. Reports Initiation of Human Trials for the Treatment of Congestive Heart Failure
9. Emisphere Technologies, Inc. Announces 2007 Third Quarter Financial Results
10. Senesco Technologies Initiates Preclinical Studies for Cancer Target
11. ASEAN News: Epeius Biotechnologies Gains Commercial Approval for Rexin-G(R), a Tumor-Targeted Gene-Based Medicine for Metastatic Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 2016 Roche (SIX: RO, ROG; OTCQX: RHHBY) ... Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated testing ... With this clearance, Roche is the first IVD company ... for sepsis risk assessment and management. PCT ... PCT levels in blood can aid clinicians in assessing ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... 52" report to their offering. ... creates a favourable commercial environment for MedImmune to enter. The ... that will serve to drive considerable growth for effective anti-influenza ... to cap sales considerably, but development is still in its ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 ... Tomorrow,s Leaders Scholarship is any indication, the future is ... online at www.diabetesscholars.org by the Diabetes Scholars ... in the way of academic and community service excellence. ... program since 2012, and continues to advocate for people ...
Breaking Medicine Technology:
(Date:6/24/2016)... , ... June 24, 2016 , ... ... and Scientific Sessions in Dallas that it will receive two significant new grants ... grants came as PHA marked its 25th anniversary by recognizing patients, medical professionals ...
(Date:6/24/2016)... ... 24, 2016 , ... Dr. Amanda Cheng, an orthodontist ... has extensive experience with all areas of orthodontics, including robotic Suresmile technology, ... , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can be used ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain ... for a minimum wage raise to $12 an hour by 2020 and then adjusting it ... the lost value of the minimum wage, assure the wage floor does not erode again, ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... at the Clinical Decision Making in Emergency Medicine conference in Ponte Vedra Beach, ... journal articles published in Emergency Medicine Practice and Pediatric Emergency Medicine ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® ... Group (TGIG), has initiated cultivation and processing operations at its production facility, and ... Nevada. , Puradigm is the manufacturer of a complete system of proactive air ...
Breaking Medicine News(10 mins):